McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
103.15B
Market cap103.15B
Price-Earnings ratio
21.56
Price-Earnings ratio21.56
Dividend yield
0.40%
Dividend yield0.40%
Average volume
1.03M
Average volume1.03M
High today
$901.99
High today$901.99
Low today
$841.02
Low today$841.02
Open price
$841.97
Open price$841.97
Volume
1.14M
Volume1.14M
52 Week high
$999.00
52 Week high$999.00
52 Week low
$637.00
52 Week low$637.00

Stock Snapshot

With a market cap of 103.15B, McKesson(MCK) trades at $891.78. The stock has a price-to-earnings ratio of 21.56 and currently yields dividends of 0.40%.

During the trading session on 2026-08-06, McKesson(MCK) shares reached a daily high of $901.99 and a low of $841.02. At a current price of $891.78, the stock is +6.0% higher than the low and still -1.1% under the high.

Trading volume for McKesson(MCK) stock has reached 1.14M, versus its average volume of 1.03M.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

MCK News

Simply Wall St 7h
Is McKesson’s Revenue Growth With Falling EPS Altering The Investment Case For McKesson?

McKesson Corporation has reported past first-quarter 2026 results, with sales rising to US$105.38 billion from US$97.83 billion a year earlier, while net income...

Is McKesson’s Revenue Growth With Falling EPS Altering The Investment Case For McKesson?
Investing.com 9h
Earnings call transcript: McKesson tops Q1 2026 estimates and lifts outlook - Investing.com

...

Earnings call transcript: McKesson tops Q1 2026 estimates and lifts outlook - Investing.com
Barron's 14h
Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Healthcare Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy. In this article XLV LLY VRTX GILD MCK Many healthcare and pharmaceutic...

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Analyst ratings

86%

of 21 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More MCK News

Simply Wall St 4d
McKesson Declares Quarterly Dividend, Is The Stock Still Undervalued?

McKesson (MCK) recently declared a quarterly dividend of US$0.94 per share, payable on October 1, 2026, with the ex dividend and record dates set for September...

McKesson Declares Quarterly Dividend, Is The Stock Still Undervalued?
Simply Wall St 6d
McKesson Stock Still Looks Reasonable On Its 345% Run

McKesson stock has delivered a very strong run over the past five years, yet the valuation checks still lean toward the shares looking cheap rather than stretch...

McKesson Stock Still Looks Reasonable On Its 345% Run

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.